炎症性肠病患者焦虑抑郁症状的持续性:纵向随访研究
本研究对已建立焦虑和抑郁轨迹的IBD患者进行纵向随访,在2年内每年收集焦虑抑郁症状数据。结果显示,24个月时仍有症状的患者更可能在第1年具有波动或持续异常/恶化的轨迹(p<0.001 for trend)。不良疾病结局与焦虑或抑郁轨迹无关。
要点
- IBD患者焦虑抑郁症状可持续较长时间。
- 第1年波动或持续异常/恶化的轨迹预测24个月时症状持续。
- 焦虑抑郁轨迹与不良疾病结局无显著关联。
核心结论
- 相当一部分IBD患者的焦虑抑郁症状持续存在。
- 焦虑抑郁轨迹与不良疾病结局无关。
研究设计与样本
- 纵向随访研究,基于每3个月收集1年症状数据建立焦虑抑郁轨迹,随后2年每年收集症状数据。
- 770例患者建立焦虑轨迹,777例建立抑郁轨迹。
主要发现
- 486例(63.1%)在12个月、358例(45.5%)在24个月提供焦虑症状数据。
- 491例(63.2%)在12个月、362例(45.6%)在24个月提供抑郁症状数据。
- 24个月有焦虑症状者更可能第1年焦虑轨迹为波动或持续异常/恶化(p<0.001 for trend)。
- 24个月有抑郁症状者更可能第1年抑郁轨迹为波动或持续异常/恶化(p<0.001 for trend)。
- 不良疾病结局( flare/需糖皮质激素、升级治疗、住院或肠切除)与焦虑或抑郁轨迹无关。
临床怎么用
- 对IBD患者应关注焦虑抑郁症状的长期持续性。
- 早期识别波动或持续异常/恶化的情绪轨迹可能有助于预测长期症状持续。
局限性
- 随访期间提供症状数据的患者比例下降(24个月时约45%)。
- 需进一步研究情绪轨迹对疾病结局的长期影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Poor psychological health affects many patients with inflammatory bowel disease (IBD), but the persistence of these symptoms is unclear. METHODS: We performed a longitudinal follow-up study of patients whose anxiety and depression trajectories were established by symptom data collected at 3-monthly intervals over the course of 1 year. We collected further anxiety and depression symptom data at yearly intervals over 2 years to determine the persistence of these symptoms in patients with IBD. Disease outcomes (flare/need for glucocorticosteroids, escalation of medical therapy, hospitalisation, or intestinal resection) were recorded to determine the effect of mood trajectories on the natural history of IBD. RESULTS: Of 770 patients with established anxiety trajectories, 486 (63.1%) provided further anxiety symptom data at 12 months, and 358 (45.5%) at 24 months. Of the 777 patients with established depression trajectories, 491 (63.2%) provided further depression symptom data at 12 months, and 362 (45.6%) at 24 months. Participants with symptoms of anxiety at 24 months were more likely to have a fluctuating, or persistently abnormal or worsening, anxiety trajectory during the first year (p < 0.001 for trend). Participants with symptoms of depression at 24 months were more likely to have a fluctuating, or persistently abnormal or worsening, depression trajectory during the first year (p < 0.001 for trend). Adverse disease outcomes were no more likely according to anxiety or depression trajectories. DISCUSSION: Poor psychological health persists for a substantial number of patients with IBD. Further work is needed to establish the long-term effect of mood trajectories on disease outcomes.
引用
- Riggott C, Fairbrass KM, Guthrie EA, et al. Persistence of Symptoms of Anxiety and Depression in Inflammatory Bowel Disease: A Longitudinal Follow-Up Study. Aliment Pharmacol Ther. 2025. PMID: 41117285. doi:10.1111/apt.70431
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。